Tilray Brands (NASDAQ:TLRY) Shares Down 3.6% - Here's What Happened

Key Points

• Tilray shares were down 3.6% to about $8.42 midday, with roughly 3.68M shares traded (≈38% below average), and the stock sits below its 50‑day ($9.46) and 200‑day ($10.95) moving averages.
• Analysts hold a consensus rating of Reduce with an average price target of $13.33, reflecting mixed views (one Buy, five Hold, two Sell) and recent downgrades and target cuts.
• Tilray reported a quarterly EPS of ($0.41) vs. ($0.14) expected, missed estimates, posted a deeply negative net margin (~251.7%), and analysts forecast about -0.2 EPS for the year.

Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report) was down 3.6% during mid-day trading on Tuesday . The company traded as low as $8.40 and last traded at $8.42. Approximately 3,676,299 shares were traded during mid-day trading, a decline of 38% from the average daily volume of 5,885,902 shares. The stock had previously closed at $8.73.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on TLRY shares. Atb Cap Markets upgraded shares of Tilray Brands from a "strong sell" rating to a "hold" rating in a report on Wednesday, December 10th. Roth Mkm cut their price target on shares of Tilray Brands from $20.00 to $10.00 and set a "neutral" rating on the stock in a report on Tuesday, January 20th. Weiss Ratings reissued a "sell (d-)" rating on shares of Tilray Brands in a research note on Wednesday, January 21st. Canaccord Genuity Group began coverage on shares of Tilray Brands in a report on Tuesday. They issued a "hold" rating for the company. Finally, Zacks Research downgraded Tilray Brands from a "hold" rating to a "strong sell" rating in a research report on Tuesday, January 13th. One research analyst has rated the stock with a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Tilray Brands has a consensus rating of "Reduce" and an average price target of $13.33.

Tilray Brands Trading Down 3.6%

The firm has a market capitalization of $980.99 million, a price-to-earnings ratio of -0.38 and a beta of 1.77. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.72 and a current ratio of 2.81. The company has a 50 day moving average price of $9.46 and a two-hundred day moving average price of $10.95.

Tilray Brands (NASDAQ:TLRY - Get Free Report) last released its earnings results on Thursday, January 8th. The company reported ($0.41) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.27). Tilray Brands had a negative return on equity of 6.35% and a negative net margin of 251.69%.The company had revenue of $217.51 million for the quarter, compared to analysts' expectations of $211.15 million. During the same period in the prior year, the firm earned ($0.03) EPS. On average, research analysts forecast that Tilray Brands, Inc. will post -0.2 EPS for the current year.

Institutional Investors Weigh In On Tilray Brands

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Silverlake Wealth Management LLC purchased a new stake in Tilray Brands in the third quarter valued at approximately $25,000. Oppenheimer & Co. Inc. acquired a new position in shares of Tilray Brands during the third quarter worth about $25,000. Unified Investment Management acquired a new stake in shares of Tilray Brands in the 3rd quarter valued at $26,000. J.W. Cole Advisors Inc. boosted its position in shares of Tilray Brands by 203.2% during the 2nd quarter. J.W. Cole Advisors Inc. now owns 71,890 shares of the company's stock worth $30,000 after acquiring an additional 48,177 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new position in Tilray Brands in the third quarter valued at approximately $30,000. Hedge funds and other institutional investors own 9.35% of the company's stock.

About Tilray Brands

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray's product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.